Novel non-invasive liver disease assessments (NILDAs) are effective alternatives to liver biopsy for the treatment of liver ...

Roche has waved goodbye to an inflammation drug from Kiniksa Pharmaceuticals—as well as the $100 million that the pharma paid for the therapy—as part of a ...

When UNSW Associate Professor Shafagh Waters explains cystic fibrosis (CF) to the children she works with, she asks them to ...

Dr. Shune concludes the discussion by focusing on safety, sequencing, and practical considerations for incorporating ...

The study also found that 93.7 per cent of those with fatty liver were obese or overweight as compared to 71.1 per cent ...

Targeted therapies for MASH show progress, with pegozafermin leading in efficacy for fibrosis regression and disease resolution. New research highlights the effectiveness of targeted therapies for ...

Care for patients with cystic fibrosis has undergone transformative changes over the past decade and serves as an example of how an understanding of the functional consequences of a genetic disease ...

In this Q&A, Avitzur breaks down the study’s findings and suggests how the information can be used to advance PF research and treatments. This transcript has been lightly edited for clarity. AJMC: ...

What if creeping fat in Crohn’s disease isn’t collateral damage, but rather the body’s attempt to trap microbiota escaping the intestine, only to become a driver of fibrosis and disease progression ...

An updated report on cystic fibrosis (CF) from Ann & Robert H. Lurie Children's Hospital of Chicago, in partnership with the ...

Clark Grady has cystic fibrosis. It hasn't stopped him from playing sports and taking the disease head on as a fundraiser.